Pulmonary hypertension in left heart disease

Pulmonary hypertension in left heart disease (PH-LHD) is the most prevalent form of PH. It is classified as group 2 PH as per WHO classification. As the prevalence of left heart disease such as congestive heart failure is increasing, the number of patients with associated PH is rising, coupled with...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pratishtha Mehra, Vimal Mehta, Rishi Sukhija, Anjan K. Sinha, Mohit Gupta, M.P. Girish, Wilbert S. Aronow
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2018
Materias:	pulmonary hypertension left heart disease congestive heart failure pre-capillary post-capillary pulmonary artery pressure Medicine R
Acceso en línea:	https://doaj.org/article/9eface15fa92451490cd28e394670d79
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9eface15fa92451490cd28e394670d79
record_format	dspace
spelling	oai:doaj.org-article:9eface15fa92451490cd28e394670d792021-12-02T18:39:09ZPulmonary hypertension in left heart disease1734-19221896-915110.5114/aoms.2017.68938https://doaj.org/article/9eface15fa92451490cd28e394670d792018-12-01T00:00:00Zhttps://www.archivesofmedicalscience.com/Pulmonary-hypertension-in-left-heart-disease,65206,0,2.htmlhttps://doaj.org/toc/1734-1922https://doaj.org/toc/1896-9151Pulmonary hypertension in left heart disease (PH-LHD) is the most prevalent form of PH. It is classified as group 2 PH as per WHO classification. As the prevalence of left heart disease such as congestive heart failure is increasing, the number of patients with associated PH is rising, coupled with high morbidity and mortality. Pulmonary hypertension is initially passive or isolated post-capillary (Ipc-PH) due to increased left sided filling pressures. In long standing cases pre-capillary component is added due to development of pulmonary vascular disease, termed combined post- and pre-capillary PH (Cpc-PH) or reactive PH. We describe the hemodynamics, pathophysiology, role of echocardiography and right heart catheterization in PH-LHD. We discuss the significance of PH associated with congestive heart failure as well as valvular heart disease. Although there is no treatment for PH-LHD, we discuss and critically analyze various studies investigating the role of pulmonary vasodilators in this condition. As PH-LHD is an under studied disease, we highlight the areas where further research is required.Pratishtha MehraVimal MehtaRishi SukhijaAnjan K. SinhaMohit GuptaM.P. GirishWilbert S. AronowTermedia Publishing Housearticlepulmonary hypertensionleft heart diseasecongestive heart failurepre-capillarypost-capillarypulmonary artery pressureMedicineRENArchives of Medical Science, Vol 15, Iss 1, Pp 262-273 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	pulmonary hypertension left heart disease congestive heart failure pre-capillary post-capillary pulmonary artery pressure Medicine R
spellingShingle	pulmonary hypertension left heart disease congestive heart failure pre-capillary post-capillary pulmonary artery pressure Medicine R Pratishtha Mehra Vimal Mehta Rishi Sukhija Anjan K. Sinha Mohit Gupta M.P. Girish Wilbert S. Aronow Pulmonary hypertension in left heart disease
description	Pulmonary hypertension in left heart disease (PH-LHD) is the most prevalent form of PH. It is classified as group 2 PH as per WHO classification. As the prevalence of left heart disease such as congestive heart failure is increasing, the number of patients with associated PH is rising, coupled with high morbidity and mortality. Pulmonary hypertension is initially passive or isolated post-capillary (Ipc-PH) due to increased left sided filling pressures. In long standing cases pre-capillary component is added due to development of pulmonary vascular disease, termed combined post- and pre-capillary PH (Cpc-PH) or reactive PH. We describe the hemodynamics, pathophysiology, role of echocardiography and right heart catheterization in PH-LHD. We discuss the significance of PH associated with congestive heart failure as well as valvular heart disease. Although there is no treatment for PH-LHD, we discuss and critically analyze various studies investigating the role of pulmonary vasodilators in this condition. As PH-LHD is an under studied disease, we highlight the areas where further research is required.
format	article
author	Pratishtha Mehra Vimal Mehta Rishi Sukhija Anjan K. Sinha Mohit Gupta M.P. Girish Wilbert S. Aronow
author_facet	Pratishtha Mehra Vimal Mehta Rishi Sukhija Anjan K. Sinha Mohit Gupta M.P. Girish Wilbert S. Aronow
author_sort	Pratishtha Mehra
title	Pulmonary hypertension in left heart disease
title_short	Pulmonary hypertension in left heart disease
title_full	Pulmonary hypertension in left heart disease
title_fullStr	Pulmonary hypertension in left heart disease
title_full_unstemmed	Pulmonary hypertension in left heart disease
title_sort	pulmonary hypertension in left heart disease
publisher	Termedia Publishing House
publishDate	2018
url	https://doaj.org/article/9eface15fa92451490cd28e394670d79
work_keys_str_mv	AT pratishthamehra pulmonaryhypertensioninleftheartdisease AT vimalmehta pulmonaryhypertensioninleftheartdisease AT rishisukhija pulmonaryhypertensioninleftheartdisease AT anjanksinha pulmonaryhypertensioninleftheartdisease AT mohitgupta pulmonaryhypertensioninleftheartdisease AT mpgirish pulmonaryhypertensioninleftheartdisease AT wilbertsaronow pulmonaryhypertensioninleftheartdisease
_version_	1718377754059079680

Pulmonary hypertension in left heart disease

Ejemplares similares